Medroxyprogesterone Acetate
NDC 70700-315, Medroxyprogesterone Acetate, injection, suspension, from Xiromed LLC.
- Product NDC
- 70700-315
- Status
- Listed
- Labeler
- Xiromed LLC
- Dosage form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210227
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70700-315 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MEDROXYPROGESTERONE ACETATE150 mg/mL
Pharmacologic classes
Progesterone Congeners [CS]; Progestin [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70700-315-25 | 70700031525 | 25 VIAL in 1 CARTON (70700-315-25) / 1 mL in 1 VIAL (70700-315-22) |
| 70700-315-27 | 70700031527 | 1 VIAL in 1 CARTON (70700-315-27) / 1 mL in 1 VIAL (70700-315-22) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/24544a5d-0cf5-a099-b57c-6e0843a40532NADAC price for package 70700031525
GET /v1/drugs/nadac/70700031525NADAC price for package 70700031527
GET /v1/drugs/nadac/70700031527
Use it
Look up 70700-315 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70700-315 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70700-315. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.